Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Respiratory Exacerbation Plans for Action and Care Transitions for Children With Severe Cerebral Palsy (CP)

NCT05292365 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT05292365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05292365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Respiratory Exacerbation Plans for Action and Care Transitions for Children With Severe Cerebral Palsy (CP)
Lead sponsor
University of Wisconsin, Madison
Phase
Not applicable
Overall status
Completed
Start date
April 27, 2022
Completion date
February 27, 2024
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral palsy